Careers  |  Sign In  |  Register

Latest in HIV/AIDS

Reuters Health • The Doctor's Channel Daily Newscast

Brain injury, cognitive impairment continue in HIV infection, despite HAART

NEW YORK (Reuters Health) — Chronically HIV-infected individuals show brain damage even when the disease is otherwise stable because of highly active antiretroviral therapy (HAART), according to a recent study by U.S. researchers. “The findings show that cognitive impairment is present in almost 50%...
NEW YORK (Reuters Health) – For initial treatment of HIV-1 infection, once daily atazanavir plus ritonavir and once-daily efavirenz provide comparable antiviral efficacy when used with either abacavir/lamivudine or tenofovir disoproxil fumarate (DF)/emtricitabine, according to research published...

Reuters Health • The Doctor's Channel Daily Newscast

Type of statins given to HIV-infected people should be reconsidered: study

Rosuvastatin should be considered for HIV-positive people with dyslipidemia — and guidelines should be updated to reflect that, suggests a new study. Although guidelines from the Infectious Diseases Society of America and the Adult AIDS Clinical Trials Group recommend pravastatin or atorvastatin for...